期刊文献+

葛根素保护压力负荷诱导的心肌肥厚 被引量:2

Puerarin Protects Pressure Overload Induced Cardiac Hypertrophy
下载PDF
导出
摘要 目的探讨葛根素在压力负荷诱导的心肌肥厚中的作用及其机制。方法雄性C57小鼠随机分为假手术组、葛根素治疗+手术组和单纯手术组。在胸主动脉缩窄术后1周开始喂药[小鼠饮食中加葛根素,给药剂量约65mg/(kg·d)持续12周,12周后取心脏,比较各组小鼠心重体重比、肺重体重比和心重胫骨长度比,同时比较各组小鼠的死亡率以评价葛根素对压力负荷诱导的心肌肥厚的影响。结果手术12周后葛根素组心重体重比、肺重体重比和心重胫骨长度比明显低于手术组,且葛根素治疗组小鼠死亡率明显下降,病理染色结果显示与手术组相比葛根素治疗组NF-κB核转位明显下降,提示葛根素可能通过NF-κB该信号通过减轻心肌肥厚。结论葛根素能减轻压力负荷诱导的心肌肥厚,其机制可能是通过抑制NF-κB信号通路发挥作用。 Objective Puerarin, main active ingredient in kudzu root, has been widely used in the treatment of cardiovascular dis- ease and diabetes in traditional Chinese medicine. Whilethe role of puerarin in cardiac hypertrophy remains unclear. To investigate the effect of puerarin in pressure overload - induced cardiac hypertrophy. Methods Aortic banding was performed to induce cardiac hypertro- phy. C57 male mice were randomly divided into sham operator group, Aortic bandingwith or without puerarin treatment. Mice were given puerarin after 1 weeks of aortic banding ,puerarin were added to the diet at a dosage of 65mg/( kg d). Heart was removed after 12 weeks of aortic banding to compare the heart weight/body weight, lung weight/body weight and heart weight/tibia length of each group as well as the mortality. Results The heart weight/body weight, lung weight/body weight and heart weight/tibia length were significant lower in pu- erarin group compared to vehicle group after 12 weeks of aortic handing. The mortality in puerarin group was also reduced after 12 weeks of aortic handing, when comparing to vehicle group. Pathological staining result showed that compared with vehiclegroup, nuclear translo- cation of NF - KB was significantly decreased in puerarin, suggesting that puerarin regulating cardiac hypertrophy may through the NF - kB signal. Conclusion Puerarin can inhibit the pressure overload induced cardiac hypertrophy, and the mechanism may be involved in theblockage of NF - KB signaling pathway.
出处 《医学研究杂志》 2015年第8期61-64,共4页 Journal of Medical Research
关键词 葛根素 心肌肥厚 压力负荷 NF—κB Puerarin Cardiac hypertrophy Pressure overload NF -kB
  • 相关文献

参考文献15

  • 1Hou J. Regression of pathological cardiac hypertrophy signaling path- ways and therapeutic targets [ J ]. Pharmacol Ther, 2012, 135 ( 3 ) : 337 - 354.
  • 2Sala V. Signaling to cardiac hypertrophy: insights from human and mouse RASopathies[J]. Mol Med, 2012, 18 (5): 938 -947.
  • 3Yamamoto S. New molecular mechanisms for cardiovascular disease: cardiac hypertrophy and cell -volume regulation [J]. J Pharmaeol Sci. , 2011 , 116(4) : 343 -349.
  • 4Kohli S, Rani V. Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy[J]. Curr Cardiol Rev, 2011, 7(4): 262 - 271.
  • 5Wong KH, Li KM, Kudzu root: traditional uses and potential medici- nal benefits in diabetes and cardiovascular diseases[ J]. J Ethnophar- maeol, 2011, 134(3): 584-607.
  • 6Wang J, Ma C. Puerarin attenuates airway inflammation by regulation ofeotaxin-3[J]. Immunol Lett, 2015,163(2) :173-178.
  • 7Wang C,Zhang H. Puerarin protects against β - amylnid - induced mieroglia apoptosis via a PI3 K - dependent signaling pathway [ J ]. Neurochem Res, 2014, 39( 11 ): 2189-2196.
  • 8Xie N, Lian Y. Puerarin protects hippocampal neurons against cell death in pilocarpine - induced seizures through antioxidant and anti - apoptotie mechanisms [ J 1. Cell Mol Neurobiol, 2014, 34 ( 8 ) :1175 -1182.
  • 9Wang L,Tang M. Puerarin facilitates T - tubule development of mu- rine embryonic stem cell - derived cardiomyoeytes [ J]. Cell Physiol Biochem, 2014, 34(2) : 383 -392.
  • 10Liu S, Xu C. Puerarin alleviates aggravated sympathoexcitatory re- sponse induced by myocardial ischemia via regulating P2X3 receptor in rat superior cervical ganglia[ J]. Neurochem Int, 2014, 70 : 39 - 49.

同被引文献28

引证文献2

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部